Baird Medical Investment Holdings (BDMD) Receivables (2023 - 2025)

Baird Medical Investment Holdings' Receivables history runs 3 years deep, the most recent figure standing at $42.8 million for Q4 2025.

• In Q4 2025, Receivables fell 15.91% year-over-year to $42.8 million; the TTM figure through Dec 2025 stood at $42.8 million (down 15.91% YoY), while the FY2025 annual figure was $42.8 million, down 15.91% from the prior year.
• Receivables was $42.8 million for Q4 2025 at Baird Medical Investment Holdings, up from $40.8 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $50.9 million in Q4 2024 to a low of -$4.1 million in Q2 2024.
• Historically, Receivables has averaged $32.9 million across 3 years, with a median of $40.8 million in 2025.
• Biggest YoY gain for Receivables was 1086.41% in 2025; the steepest drop was 15.91% in 2025.
• A 3-year view of Receivables shows it stood at $34.3 million in 2023, then jumped by 48.27% to $50.9 million in 2024, then fell by 15.91% to $42.8 million in 2025.
• The last three Receivables figures came in at $42.8 million (Q4 2025), $40.8 million (Q2 2025), and $50.9 million (Q4 2024), per Business Quant data.